UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Chubb
CB
|
+$745M |
| 2 |
Spotify
SPOT
|
+$727M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$689M |
| 4 |
Meta Platforms (Facebook)
META
|
+$680M |
| 5 |
NXP Semiconductors
NXPI
|
+$573M |
Top Sells
| 1 |
Prologis
PLD
|
+$1.33B |
| 2 |
Union Pacific
UNP
|
+$1.2B |
| 3 |
Equinix
EQIX
|
+$929M |
| 4 |
Broadcom
AVGO
|
+$805M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$685M |
Sector Composition
| 1 | Technology | 37.43% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.57% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
AdaptHealth
AHCO
$1.39B
| $2.17M | ﹤0.01% |
218,238
+3,919
| +2% | +$37.4K |
|
1852
American Express Global Business Travel
GBTG
$4.91B
| $2.17M | ﹤0.01% |
283,468
+40,645
| +17% | +$315K |
|
1853
Gorman-Rupp
GRC
$2.11B
| $2.17M | ﹤0.01% |
45,370
+203
| +0.4% | +$9.45K |
|
1854
US Physical Therapy
USPH
$1.07B
| $2.16M | ﹤0.01% |
27,647
-133
| -0.5% | -$10.8K |
|
1855
Nicolet Bankshares
NIC
$3.5B
| $2.16M | ﹤0.01% |
17,790
-1,394
| -7% | -$176K |
|
1856
Energy Recovery
ERII
$446M
| $2.15M | ﹤0.01% |
159,654
-9,011
| -5% | -$137K |
|
1857
Intellia Therapeutics
NTLA
$1.86B
| $2.15M | ﹤0.01% |
239,247
-2,035
| -0.8% | -$28K |
|
|
THR
1858
DELISTED
Thermon Group Holdings
THR
| $2.13M | ﹤0.01% |
57,437
+1,914
| +3% | +$62.8K |
|
|
MFA
1859
MFA Financial
MFA
$961M
| $2.12M | ﹤0.01% |
+227,366
| New | +$2.12M |
|
1860
Gentherm
THRM
$1.1B
| $2.11M | ﹤0.01% |
57,964
+177
| +0.3% | +$6.37K |
|
1861
Astrana Health
ASTH
$2.43B
| $2.1M | ﹤0.01% |
84,712
-750
| -0.9% | -$19.9K |
|
1862
PACS Group
PACS
$7.11B
| $2.1M | ﹤0.01% |
54,742
+6,124
| +13% | +$134K |
|
1863
TFS Financial
TFSL
$4.96B
| $2.1M | ﹤0.01% |
156,933
-2,037
| -1% | -$27.9K |
|
|
INVX
1864
Innovex International
INVX
$1.8B
| $2.09M | ﹤0.01% |
95,619
+6,315
| +7% | +$132K |
|
1865
Monarch Casino & Resort
MCRI
$2.23B
| $2.07M | ﹤0.01% |
21,587
+2,682
| +14% | +$258K |
|
1866
Ducommun
DCO
$2.55B
| $2.06M | ﹤0.01% |
21,675
+219
| +1% | +$20.4K |
|
1867
Westamerica Bancorp
WABC
$1.38B
| $2.04M | ﹤0.01% |
42,725
+201
| +0.5% | +$9.64K |
|
1868
Spyre Therapeutics
SYRE
$8.59B
| $2.04M | ﹤0.01% |
62,216
+22,718
| +58% | +$594K |
|
1869
1st Source
SRCE
$1.96B
| $2.03M | ﹤0.01% |
32,423
-436
| -1% | -$27K |
|
1870
Ouster
OUST
$2.82B
| $2.02M | ﹤0.01% |
93,371
+2,261
| +2% | +$59.7K |
|
1871
Unilever
UL
$131B
| $2.02M | ﹤0.01% |
+30,852
| New | +$2.07M |
|
1872
PureCycle Technologies
PCT
$1.36B
| $2.02M | ﹤0.01% |
234,695
+12,749
| +6% | +$135K |
|
1873
Cohu
COHU
$2.63B
| $2.01M | ﹤0.01% |
86,567
+29,760
| +52% | +$682K |
|
1874
Pennant Group
PNTG
$1.38B
| $2.01M | ﹤0.01% |
71,539
+2,881
| +4% | +$76.6K |
|
1875
Merchants Bancorp
MBIN
$2.23B
| $2.01M | ﹤0.01% |
58,969
+34,083
| +137% | +$1.12M |
|
Similar funds
